Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (111-120 of 272) with videos related to

Pageof 28
Sort By:
Cancer Chemotherapy and Pharmacology|February 2, 2006
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumorMichael Froehner, Bettina Beuthien-Baumann, Dag-Daniel Dittert, et al.
Molecular and Cellular Endocrinology|November 22, 2008
Differential expression and action of Toll-like receptors in human adrenocortical cellsWaldemar Kanczkowski, Kai Zacharowski, Manfred P Wirth, et al.
Urology|January 9, 2017
Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate CancerMichael Froehner, Friederike Kuithan, Klaus Zöphel, et al.
Urologia Internationalis|December 22, 2012
Urinary tract-related quality of life after radical prostatectomy: open retropubic versus robot-assisted laparoscopic approachMichael Froehner, Rainer Koch, Steffen Leike, et al.
Case Reports in Urology|April 12, 2017
PSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy FindingsMichael Froehner, Marieta Toma, Klaus Zöphel, et al.
Urology|April 26, 2020
Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical ProstatectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
Journal of Cancer Research and Clinical Oncology|August 27, 2016
MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cellsKati Erdmann, Knut Kaulke, Christiane Rieger, et al.
BJU International|February 5, 2009
Derivatives of prostate-specific antigen as predictors of incidental prostate cancerMichael Froehner, Lena Marie Buck, Rainer Koch, et al.
Cancers|November 12, 2013
Tumor-associated antigens for specific immunotherapy of prostate cancerAndrea Kiessling, Rebekka Wehner, Susanne Füssel, et al.
Urologic Oncology|August 14, 2016
An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Pageof 28

Showing results (111-120 of 272) with videos related to

Sort By:
Pageof 28
Cancer Chemotherapy and Pharmacology|February 2, 2006
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumorMichael Froehner, Bettina Beuthien-Baumann, Dag-Daniel Dittert, et al.
Molecular and Cellular Endocrinology|November 22, 2008
Differential expression and action of Toll-like receptors in human adrenocortical cellsWaldemar Kanczkowski, Kai Zacharowski, Manfred P Wirth, et al.
Urology|January 9, 2017
Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate CancerMichael Froehner, Friederike Kuithan, Klaus Zöphel, et al.
Urologia Internationalis|December 22, 2012
Urinary tract-related quality of life after radical prostatectomy: open retropubic versus robot-assisted laparoscopic approachMichael Froehner, Rainer Koch, Steffen Leike, et al.
Case Reports in Urology|April 12, 2017
PSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy FindingsMichael Froehner, Marieta Toma, Klaus Zöphel, et al.
Urology|April 26, 2020
Quantifying the Relationship Between Increasing Life Expectancy and Nonprostate Cancer Mortality After Radical ProstatectomyMichael Froehner, Rainer Koch, Matthias Hübler, et al.
Journal of Cancer Research and Clinical Oncology|August 27, 2016
MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cellsKati Erdmann, Knut Kaulke, Christiane Rieger, et al.
BJU International|February 5, 2009
Derivatives of prostate-specific antigen as predictors of incidental prostate cancerMichael Froehner, Lena Marie Buck, Rainer Koch, et al.
Cancers|November 12, 2013
Tumor-associated antigens for specific immunotherapy of prostate cancerAndrea Kiessling, Rebekka Wehner, Susanne Füssel, et al.
Urologic Oncology|August 14, 2016
An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Pageof 28